Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENERGI-F703 GEL for Venous Leg Ulcer
NCT04078555Phase 2Recruiting
- Sponsor
- Energenesis Biomedical Co., Ltd.
- Start
- Jul 2022
- Primary completion
- Mar 2025
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ENERGI-F703EB Cream in venous leg ulcer (VLU), sponsored by Energenesis Biomedical Co., Ltd.. Started Jul 2022; status: recruiting.
02
Drugs
ENERGI-F703EB Cream
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT04078555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078555.